Basic Neurosciences · Paper A
Blood-brain barrier
The blood-brain barrierA protective filter of tightly packed cells that limits which substances can pass from the blood into the brain.Read more → matters because it decides which drugs can reach the brain at all. This is why some psychiatric treatments work while their close chemical relatives do not. It is a selective barrier formed by tightly sealed brain capillary cells, called tight junctions, wrapped by astrocyte end-feet (the supporting foot-like processes of astrocyte glial cells). For example, imagine two similar molecules, one lipophilic (fat-soluble) and one charged (electrically charged, water-soluble): only the lipophilic one crosses easily into the brain. In practice, this is exactly why levodopa (L-DOPA) treats Parkinson's disease while dopamine itself, given as a tablet, cannot.
Tight junctions between the endothelial (lining) cells of brain capillaries block substances that would normally leak through gaps in blood vessels elsewhere in the body. Astrocyte end-feet wrap around these capillaries and support this barrier function. Lipophilic and small uncharged molecules cross the blood-brain barrierA protective filter of tightly packed cells that limits which substances can pass from the blood into the brain.Read more → relatively easily, while charged or large molecules are largely excluded unless an active transporter carries them across. Circumventricular organs, small brain regions such as the area postrema, lack a full blood-brain barrier, letting them sense circulating hormones and toxins directly. Say a patient is given intravenous dopamine for low blood pressure: the dopamine cannot cross the barrier to treat their Parkinson's disease. In practice, oral levodopa, its lipophilic precursor, does cross, and drug design for brain conditions often modifies a molecule specifically to improve this crossing.